£107.30

Springer Lipid A in Cancer Therapy: 667 (Advances in Experimental Medicine and Biology, 667)

Price data checked 3 days ago

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

About as cheap as it gets. The only time it was cheaper was 3 months ago.

£107 today · all-time low £107 (Feb 2026) · usually £108

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 88 days • 88 data points

Historical
Generating forecast...
£107.98 £107.20 £107.37 £107.54 £107.71 £107.88 £108.05 20 February 2026 13 March 2026 04 April 2026 26 April 2026 18 May 2026

Price Distribution

Price distribution over 88 days • 2 price levels

Days at Price
Current Price
73 days · current 15 days 0 18 37 55 73 £107 £108 Days at Price

Price Analysis

Most common price: £107 (73 days, 83.0%)

Price range: £107 - £108

Price levels: 2 different prices over 88 days

Description

The work needed to develop lipid A as an effective anti-cancer agent lies ahead in the near future. This volume is a timely contribution and provides a much needed up-to-date overview of the chemical, biological and physiological aspects of lipid A. About the Author Jean-François Jeannin is Professor of Immunology at Ecole Practique des Hautes Etudes (EPHE) and director of the EPHE Tumor Immunology and Immunotherapy Laboratory, an INSERM (National Institute of Health and Medical Research) team. His main research interests have included the effects of lipopolysaccharides in the tumor immune response and the immunotherapy of colon cancer with lipid A. Now he is investigating mechanisms of immunotherapy with synthetic lipid A analogs in cancer patients and animal cancer models. He is especially interested in the sensitization of tumor cell death by nitric oxide produced in tumors during lipid A immunotherapy. Jean-François Jeannin has been Dean and President of the Life Sciences faculty of EPHE and a member of numerous scientific organizations.

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
25 February 2012
Listed Since
16 December 2011

Barcode

No barcode data available

Similar Products You Might Like

Advances in Tumor Immunology and Immunotherapy (Current Cancer Research)
77% match

Advances in Tumor Immunology and Immunotherapy (Current Cancer Research)

Springer

£111.48 18 May 2026
Gene-Based Therapies for Cancer (Current Cancer Research)
77% match

Gene-Based Therapies for Cancer (Current Cancer Research)

Springer

£107.50 18 May 2026
Lymphangiogenesis in Cancer Metastasis: 13 (Cancer Metastasis - Biology and Treatment, 13)
77% match

Lymphangiogenesis in Cancer Metastasis: 13 (Cancer Metastasis - Biology and Treatment, 13)

Springer

£113.76 11 May 2026
Lipid Metabolism in Tumor Immunity: 1316 (Advances in Experimental Medicine and Biology, 1316)
76% match

Lipid Metabolism in Tumor Immunity: 1316 (Advances in Experimental Medicine and Biology, 1316)

Springer

£107.98 11 May 2026
Lipid Metabolism in Tumor Immunity: 1316 (Advances in Experimental Medicine and Biology, 1316)
76% match

Lipid Metabolism in Tumor Immunity: 1316 (Advances in Experimental Medicine and Biology, 1316)

Springer

£106.59 04 May 2026
Metabolism in Cancer: 207 (Recent Results in Cancer Research, 207)
76% match

Metabolism in Cancer: 207 (Recent Results in Cancer Research, 207)

Springer

£73.10 18 May 2026
General Principles of Tumor Immunotherapy: Basic and Clinical Applications of Tumor Immunology
76% match

General Principles of Tumor Immunotherapy: Basic and Clinical Applications of Tumor Immunology

Springer

£147.83 11 May 2026
Leukemia: Advances in Research and Treatment: 64 (Cancer Treatment and Research, 64)
76% match

Leukemia: Advances in Research and Treatment: 64 (Cancer Treatment and Research, 64)

Springer

£77.37 18 May 2026
Obesity, Inflammation and Cancer: 7 (Energy Balance and Cancer, 7)
76% match

Obesity, Inflammation and Cancer: 7 (Energy Balance and Cancer, 7)

Springer

£107.98 18 May 2026
Epigenetic Mechanisms in Breast Cancer Therapy and Resistance (Advances in Experimental Medicine and Biology, 1465)
76% match

Epigenetic Mechanisms in Breast Cancer Therapy and Resistance (Advances in Experimental Medicine and Biology, 1465)

Springer

£127.59 14 May 2026
Cancer Immunotherapy: Paradigms, Practice and Promise
76% match

Cancer Immunotherapy: Paradigms, Practice and Promise

Springer

£108.92 18 May 2026
Towards Dual and Targeted Cancer Therapy with Novel Phthalocyanine-based Photosensitizers (Springer Theses)
76% match

Towards Dual and Targeted Cancer Therapy with Novel Phthalocyanine-based Photosensitizers (Springer Theses)

Springer

£74.58 11 May 2026
Non-coding RNAs in Colorectal Cancer: 937 (Advances in Experimental Medicine and Biology, 937)
76% match

Non-coding RNAs in Colorectal Cancer: 937 (Advances in Experimental Medicine and Biology, 937)

Springer

£107.98 18 May 2026
Cancer Genetics and Therapeutics: Focus on Phytochemicals
76% match

Cancer Genetics and Therapeutics: Focus on Phytochemicals

Springer

£74.27 18 May 2026
Cytokines and Cancer: 126 (Cancer Treatment and Research, 126)
76% match

Cytokines and Cancer: 126 (Cancer Treatment and Research, 126)

Springer

£113.76 18 May 2026
Molecular Basis for Therapy of AIDS-Defining Cancers
76% match

Molecular Basis for Therapy of AIDS-Defining Cancers

Springer

£107.57 18 May 2026
Tumor Cell Metabolism: Pathways, Regulation and Biology
75% match

Tumor Cell Metabolism: Pathways, Regulation and Biology

Springer

£76.38 18 May 2026
Drug Resistance in Cancer Therapy: 48 (Cancer Treatment and Research, 48)
75% match

Drug Resistance in Cancer Therapy: 48 (Cancer Treatment and Research, 48)

Springer

£113.76 18 May 2026
Molecular Mechanisms of Tumor Cell Resistance to Chemotherapy: Targeted Therapies to Reverse Resistance: 1 (Resistance to Targeted Anti-Cancer Therapeutics, 1)
75% match

Molecular Mechanisms of Tumor Cell Resistance to Chemotherapy: Targeted Therapies to Reverse Resistance: 1 (Resistance to Targeted Anti-Cancer Therapeutics, 1)

Springer

£107.98 18 May 2026
Bioactive Essential Oils and Cancer
75% match

Bioactive Essential Oils and Cancer

Springer

£107.98 19 May 2026
Cancer Chemotherapy: Concepts, Clinical Investigations and Therapeutic Advances: 42 (Cancer Treatment and Research, 42)
75% match

Cancer Chemotherapy: Concepts, Clinical Investigations and Therapeutic Advances: 42 (Cancer Treatment and Research, 42)

Springer

£107.85 18 May 2026
Polymer Drugs in the Clinical Stage: Advantages and Prospects: 519 (Advances in Experimental Medicine and Biology, 519)
75% match

Polymer Drugs in the Clinical Stage: Advantages and Prospects: 519 (Advances in Experimental Medicine and Biology, 519)

Springer

£107.98 18 May 2026
75% match

Molecular Mechanisms of Cancer Resistance: Emerging Technologies and Therapeutic Strategies (Novel approaches to overcome cancer resistance to conventional therapies)

Academic Press

£153.99 11 May 2026
Advances in Biology and Therapy of Multiple Myeloma: Volume 1: Basic Science
75% match

Advances in Biology and Therapy of Multiple Myeloma: Volume 1: Basic Science

Springer

£107.98 18 May 2026